• Return to Headlines

Stemline Therape Up 83.7% Since SmarTrend Uptrend Call (STML)

By Nick Russo

SmarTrend identified an Uptrend for Stemline Therape (NASDAQ:STML) on September 6th, 2017 at $9.17. In approximately 6 months, Stemline Therape has returned 83.65% as of today's recent price of $16.85.

Stemline Therape share prices have moved between a 52-week high of $18.75 and a 52-week low of $5.50 and are now trading 206% above that low price at $16.85 per share. The 200-day and 50-day moving averages have moved 2.03% lower and 1.71% higher over the past week, respectively.

Stemline Therapeutics Inc. provides biopharmaceutical services. The Company offers research, discovery, and development of novel compounds that target cancer stem cells.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Stemline Therape shares.

Log in and add Stemline Therape (STML) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights stemline therape

Ticker(s): STML